{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:33:03Z","timestamp":1790674383968,"version":"4.1.0"},"reference-count":47,"publisher":"Tsinghua University Press","issue":"9","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nano Res."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12274-022-4482-4","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T11:09:10Z","timestamp":1656673750000},"page":"8304-8314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice"],"prefix":"10.26599","volume":"15","author":[{"given":"Yongbo","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaXin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"4482_CR1","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/d41586-019-02751-w","volume":"573","author":"M Eisenstein","year":"2019","unstructured":"Eisenstein, M. Towards a universal flu vaccine. Nature 2019, 573, S50\u2013S52.","journal-title":"Nature"},{"key":"4482_CR2","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1007\/s12274-021-4011-x","volume":"15","author":"M Xia","year":"2022","unstructured":"Xia, M.; Hoq, M. R.; Huang, P. W.; Jiang, W.; Jiang, X.; Tan, M. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Res. 2022, 15, 4181\u20134190.","journal-title":"Nano Res."},{"key":"4482_CR3","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","volume":"219","author":"F Krammer","year":"2019","unstructured":"Krammer, F.; Palese, P. Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain. J. Infect. Dis. 2019, 219, S62\u2013S67.","journal-title":"J. Infect. Dis."},{"key":"4482_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/v13060973","volume":"13","author":"Q T Nguyen","year":"2021","unstructured":"Nguyen, Q. T.; Choi, Y. K. Targeting antigens for universal influenza vaccine development. Viruses 2021, 13, 973.","journal-title":"Viruses"},{"key":"4482_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","volume":"71","author":"R Nachbagauer","year":"2020","unstructured":"Nachbagauer, R.; Palese, P. Is a universal influenza virus vaccine possible. Annu. Rev. Med. 2020, 71, 315\u2013327.","journal-title":"Annu. Rev. Med."},{"key":"4482_CR6","doi-asserted-by":"publisher","first-page":"20248","DOI":"10.1073\/pnas.1320524110","volume":"110","author":"N S Heaton","year":"2013","unstructured":"Heaton, N. S.; Sachs, D.; Chen, C. J.; Hai, R.; Palese, P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc. Natl. Acad. Sci. USA 2013, 110, 20248\u201320253.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4482_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1172\/JCI123366","volume":"129","author":"H X Tan","year":"2019","unstructured":"Tan, H. X.; Jegaskanda, S.; Juno, J. A.; Esterbauer, R.; Wong, J.; Kelly, H. G.; Liu, Y.; Tilmanis, D.; Hurt, A. C.; Yewdell, J. W. et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J. Clin. Invest. 2019, 129, 850\u2013862.","journal-title":"J. Clin. Invest."},{"key":"4482_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","volume":"11","author":"O A Vogel","year":"2020","unstructured":"Vogel, O. A.; Manicassamy, B. Broadly protective strategies against influenza viruses: Universal vaccines and therapeutics. Front. Microbiol. 2020, 11, 135.","journal-title":"Front. Microbiol."},{"key":"4482_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","volume":"3","author":"F Krammer","year":"2013","unstructured":"Krammer, F.; Palese, P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr. Opin. Virol. 2013, 3, 521\u2013530.","journal-title":"Curr. Opin. Virol."},{"key":"4482_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","volume":"9","author":"Y H Jang","year":"2019","unstructured":"Jang, Y. H.; Seong, B. L. The quest for a truly universal influenza vaccine. Front. Cell. Infect. Microbiol. 2019, 9, 344.","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"4482_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/C5SC03892H","volume":"7","author":"M Skwarczynski","year":"2016","unstructured":"Skwarczynski, M.; Toth, I. Peptide-based synthetic vaccines. Chem. Sci. 2016, 7, 842\u2013854.","journal-title":"Chem. Sci."},{"key":"4482_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1586\/erv.10.123","volume":"9","author":"S L Epstein","year":"2010","unstructured":"Epstein, S. L.; Price, G. E. Cross-protective immunity to influenza a viruses. Expert Rev. Vaccines 2010, 9, 1325\u20131341.","journal-title":"Expert Rev. Vaccines"},{"key":"4482_CR13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1093\/aje\/kwy145","volume":"187","author":"S L Epstein","year":"2018","unstructured":"Epstein, S. L. Universal influenza vaccines: Progress in achieving broad cross-protection in vivo. Am. J. Epidemiol. 2018, 187, 2603\u20132614.","journal-title":"Am. J. Epidemiol."},{"key":"4482_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","volume":"32","author":"J Atsmon","year":"2012","unstructured":"Atsmon, J.; Kate-Ilovitz, E.; Shaikevich, D.; Singer, Y.; Volokhov, I.; Haim, K. Y.; Ben-Yedidia, T. Safety and immunogenicity of multimeric-001\u2014 A novel universal influenza vaccine. J. Clin. Immunol. 2012, 32, 595\u2013603.","journal-title":"J. Clin. Immunol."},{"key":"4482_CR15","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/eji.200737254","volume":"37","author":"G A Stoloff","year":"2007","unstructured":"Stoloff, G. A.; Caparros-Wanderley, W. Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes. Eur. J. Immunol. 2007, 37, 2441\u20132449.","journal-title":"Eur. J. Immunol."},{"key":"4482_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.vaccine.2014.06.006","volume":"33","author":"J N Francis","year":"2015","unstructured":"Francis, J. N.; Bunce, C. J.; Horlock, C.; Watson, J. M.; Warrington, S. J.; Georges, B.; Brown, C. B. A novel peptide-based paninfluenza a vaccine: A double blind, randomised clinical trial of immunogenicity and safety. Vaccine 2015, 33, 396\u2013402.","journal-title":"Vaccine"},{"key":"4482_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","volume":"35","author":"M Negahdaripour","year":"2017","unstructured":"Negahdaripour, M.; Golkar, N.; Hajighahramani, N.; Kianpour, S.; Nezafat, N.; Ghasemi, Y. Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnol. Adv. 2017, 35, 575\u2013596.","journal-title":"Biotechnol. Adv."},{"key":"4482_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41392-021-00750-w","volume":"6","author":"W Q Sun","year":"2021","unstructured":"Sun, W. Q.; He, L. H.; Zhang, H.; Tian, X. D.; Bai, Z. H.; Sun, L.; Yang, L. M.; Jia, X. J.; Bi, Y. H.; Luo, T. R. et al. The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice. Signal Transduct Targeted Ther. 2021, 6, 340.","journal-title":"Signal Transduct Targeted Ther."},{"key":"4482_CR19","doi-asserted-by":"publisher","first-page":"2000087","DOI":"10.1002\/biot.202000087","volume":"15","author":"J D Pan","year":"2020","unstructured":"Pan, J. D.; Cui, Z. Q. Self-assembled nanoparticles: Exciting platforms for vaccination. Biotechnol. J. 2020, 15, 2000087.","journal-title":"Biotechnol. J."},{"key":"4482_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","volume":"14","author":"J L\u00f3pez-Sagaseta","year":"2016","unstructured":"L\u00f3pez-Sagaseta, J.; Malito, E.; Rappuoli, R.; Bottomley, M. J. Self-assembling protein nanoparticles in the design of vaccines. Comput. Struct. Biotechnol. J. 2016, 14, 58\u201368.","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"4482_CR21","doi-asserted-by":"publisher","first-page":"53630","DOI":"10.1021\/acsami.1c16989","volume":"13","author":"S Li","year":"2021","unstructured":"Li, S.; Wang, B.; Jiang, S.; Pan, Y.; Shi, Y. H.; Kong, W.; Shan, Y. M. Surface-functionalized silica-coated calcium phosphate nanoparticles efficiently deliver DNA-based HIV-1 trimeric envelope vaccines against HIV-1. ACS Appl. Mater. Interfaces 2021, 13, 53630\u201353645.","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"4482_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-021-01229-0","volume":"20","author":"B Wang","year":"2022","unstructured":"Wang, B.; Li, S.; Qiao, Y. B.; Fu, Y.; Nie, J. J.; Jiang, S.; Yao, X.; Pan, Y.; Zhao, L. Y.; Wu, C. M. et al. Self-assembling ferritin nanoparticles coupled with linear sequences from canine distemper virus haemagglutinin protein elicit robust immune responses. J. Nanobiotechnol. 2022, 20, 32.","journal-title":"J. Nanobiotechnol."},{"key":"4482_CR23","doi-asserted-by":"publisher","unstructured":"Qiao, Y. B.; Jin, S. H.; Nie, J. J.; Chang, Y. T.; Wang, B.; Guan, S. S.; Li, Q. H.; Shi, Y. H.; Kong, W.; Shan, Y. M. Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza. J. Leukocyte Biol., in press, https:\/\/doi.org\/10.1002\/jlb.6a1021-535r.","DOI":"10.1002\/jlb.6a1021-535r"},{"key":"4482_CR24","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1039\/D1NR08460G","volume":"14","author":"Y B Qiao","year":"2022","unstructured":"Qiao, Y. B.; Li, S.; Jin, S. H.; Pan, Y.; Shi, Y. H.; Kong, W.; Shan, Y. M. A self-assembling nanoparticle vaccine targeting the conserved epitope of influenza virus hemagglutinin stem elicits a cross-protective immune response. Nanoscale 2022, 14, 3250\u20133260.","journal-title":"Nanoscale"},{"key":"4482_CR25","doi-asserted-by":"publisher","first-page":"e1297","DOI":"10.1002\/cti2.1297","volume":"10","author":"N Kavian","year":"2021","unstructured":"Kavian, N.; Hachim, A.; Cowling, B. J.; Valkenburg, S. A. Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses. Clin. Transl. Immunol. 2021, 10, e1297.","journal-title":"Clin. Transl. Immunol."},{"key":"4482_CR26","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1128\/JVI.00273-13","volume":"87","author":"V Srivastava","year":"2013","unstructured":"Srivastava, V.; Yang, Z.; Hung, I. F. N.; Xu, J. Q.; Zheng, B. J.; Zhang, M. Y. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus. J. Virol. 2013, 87, 5831\u20135840.","journal-title":"J. Virol."},{"key":"4482_CR27","doi-asserted-by":"publisher","first-page":"571999","DOI":"10.3389\/fvets.2020.571999","volume":"7","author":"S Kalaiyarasu","year":"2020","unstructured":"Kalaiyarasu, S.; Bhatia, S.; Mishra, N.; Senthil Kumar, D.; Kumar, M.; Sood, R.; Rajukumar, K.; Ponnusamy, B.; Desai, D.; Singh, V. P. Elicitation of highly pathogenic avian influenza H5N1 M2e and HA2-specific humoral and cell-mediated immune response in chicken following immunization with recombinant M2e-HA2 fusion protein. Front. Vet. Sci. 2020, 7, 571999.","journal-title":"Front. Vet. Sci."},{"key":"4482_CR28","doi-asserted-by":"publisher","first-page":"1703207","DOI":"10.1002\/smll.201703207","volume":"14","author":"M Qi","year":"2018","unstructured":"Qi, M.; Zhang, X. E.; Sun, X. X.; Zhang, X. W.; Yao, Y. F.; Liu, S. L.; Chen, Z.; Li, W.; Zhang, Z. P.; Chen, J. J. et al. Intranasal nanovaccine confers homo- and hetero-subtypic influenza protection. Small 2018, 14, 1703207.","journal-title":"Small"},{"key":"4482_CR29","doi-asserted-by":"publisher","first-page":"18979","DOI":"10.1073\/pnas.1013387107","volume":"107","author":"T T Wang","year":"2010","unstructured":"Wang, T. T.; Tan, G. S.; Hai, R.; Pica, N.; Ngai, L.; Ekiert, D. C.; Wilson, I. A.; Garcia-Sastre, A.; Moran, T. M.; Palese, P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl. Acad. Sci. USA 2010, 107, 18979\u201318984.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4482_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","volume":"7","author":"A E Powell","year":"2021","unstructured":"Powell, A. E.; Zhang, K. M.; Sanyal, M.; Tang, S. G.; Weidenbacher, P. A.; Li, S. S.; Pham, T. D.; Pak, J. E.; Chiu, W.; Kim, P. S. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice. ACS Cent. Sci. 2021, 7, 183\u2013199.","journal-title":"ACS Cent. Sci."},{"key":"4482_CR31","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1038\/emi.2016.51","volume":"5","author":"X Gong","year":"2016","unstructured":"Gong, X.; Yin, H.; Shi, Y. H.; He, X. Q.; Yu, Y. J.; Guan, S. S.; Kuai, Z. Y.; Haji, N. M.; Haji, N. M.; Kong, W. et al. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus p particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. Emerg. Microbes Infect. 2016, 5, e51.","journal-title":"Emerg. Microbes Infect."},{"key":"4482_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A.; Milder, F.; Kuipers, H.; Wagner, M. V.; Zhu, X. Y.; Hoffman, R. M. B.; van Meersbergen, R.; Huizingh, J.; Wanningen, P.; Verspuij, J. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 2015, 349, 1301\u20131306.","journal-title":"Science"},{"key":"4482_CR33","doi-asserted-by":"publisher","first-page":"10722","DOI":"10.1021\/acsnano.1c04078","volume":"15","author":"S Kang","year":"2021","unstructured":"Kang, S.; Kim, Y.; Shin, Y.; Song, J. J.; Jon, S. Antigen-presenting, self-assembled protein nanobarrels as an adjuvant-free vaccine platform against influenza virus. ACS Nano 2021, 15, 10722\u201310732.","journal-title":"ACS Nano"},{"key":"4482_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1021\/nl504798g","volume":"15","author":"W W Gao","year":"2015","unstructured":"Gao, W. W.; Fang, R. H.; Thamphiwatana, S.; Luk, B. T.; Li, J. M.; Angsantikul, P.; Zhang, Q. Z.; Hu, C. M.; Zhang, L. F. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 2015, 15, 1403\u20131409.","journal-title":"Nano Lett."},{"key":"4482_CR35","doi-asserted-by":"publisher","first-page":"e65536","DOI":"10.1371\/journal.pone.0065536","volume":"8","author":"F P Ming","year":"2013","unstructured":"Ming, F. P.; Yang, J.; Chu, P. P.; Ma, M. P.; Shi, J. Q.; Cai, H. M.; Huang, C. Y.; Li, H. Z.; Jiang, Z. G.; Wang, H. G. et al. Immunization of aged pigs with attenuated pseudorabies virus vaccine combined with CpG oligodeoxynucleotide restores defective Th1 immune responses. PLoS One 2013, 8, e65536.","journal-title":"PLoS One"},{"key":"4482_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","volume":"16","author":"A Kolpe","year":"2017","unstructured":"Kolpe, A.; Schepens, B.; Fiers, W.; Saelens, X. M2-based influenza vaccines: Recent advances and clinical potential. Expert Rev. Vaccines 2017, 16, 123\u2013136.","journal-title":"Expert Rev. Vaccines"},{"key":"4482_CR37","first-page":"901817","volume":"2015","author":"S H Chen","year":"2015","unstructured":"Chen, S. H.; Zheng, D.; Li, C. G.; Zhang, W. J.; Xu, W. T.; Liu, X. Y.; Fang, F.; Chen, Z. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope. Biomed Res. Int. 2015, 2015, 901817.","journal-title":"Biomed Res. Int."},{"key":"4482_CR38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jviromet.2013.08.022","volume":"194","author":"J S Lee","year":"2013","unstructured":"Lee, J. S.; Chowdhury, M. Y. E.; Moon, H. J.; Choi, Y. K.; Talactac, M. R.; Kim, J. H.; Park, M. E.; Son, H. Y.; Shin, K. S.; Kim, C. J. The highly conserved HA2 protein of the influenza a virus induces a cross protective immune response. J. Virol. Methods 2013, 194, 280\u2013288.","journal-title":"J. Virol. Methods"},{"key":"4482_CR39","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.vaccine.2021.07.037","volume":"39","author":"I G Sakala","year":"2021","unstructured":"Sakala, I. G.; Honda-Okubo, Y.; Li, L.; Baldwin, J.; Petrovsky, N. A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization. Vaccine 2021, 39, 5162\u20135172.","journal-title":"Vaccine"},{"key":"4482_CR40","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.0803467","volume":"182","author":"L L M Poon","year":"2009","unstructured":"Poon, L. L. M.; Leung, Y. H. C.; Nicholls, J. A.; Perera, P. Y.; Lichy, J. H.; Yamamoto, M.; Waldmann, T. A.; Peiris, J. S. M.; Perera, L. P. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J. Immunol. 2009, 182, 3063\u20133071.","journal-title":"J. Immunol."},{"key":"4482_CR41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W J Wang","year":"2020","unstructured":"Wang, W. J.; Zhou, X. X.; Bian, Y. J.; Wang, S.; Chai, Q.; Guo, Z. Q.; Wang, Z. N.; Zhu, P.; Peng, H.; Yan, X. Y. et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nature Nanotechnology 2020, 15, 406\u2013416.","journal-title":"Nature Nanotechnology"},{"key":"4482_CR42","doi-asserted-by":"publisher","first-page":"e02810","DOI":"10.1128\/mBio.02810-18","volume":"10","author":"K S Corbett","year":"2019","unstructured":"Corbett, K. S.; Moin, S. M.; Yassine, H. M.; Cagigi, A.; Kanekiyo, M.; Boyoglu-Barnum, S.; Myers, S. I.; Tsybovsky, Y.; Wheatley, A. K.; Schramm, C. A. et al. Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages. Mbio 2019, 10, e02810\u201318.","journal-title":"Mbio"},{"key":"4482_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X C Ma","year":"2020","unstructured":"Ma, X. C.; Zou, F.; Yu, F.; Li, R.; Yuan, Y. C.; Zhang, Y. W.; Zhang, X. T.; Deng, J. Y.; Chen, T.; Song, Z. et al. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 2020, 53, 1315\u20131330.e9.","journal-title":"Immunity"},{"key":"4482_CR44","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.nano.2021.102463","volume":"39","author":"A A Zykova","year":"2022","unstructured":"Zykova, A. A.; Blokhina, E. A.; Stepanova, L. A.; Shuklina, M. A.; Tsybalova, L. M.; Kuprianov, V. V.; Ravin, N. V. Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection. Nanomedicine 2022, 39, 102463.","journal-title":"Nanomedicine"},{"key":"4482_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2018.00276","volume":"9","author":"E Panagioti","year":"2018","unstructured":"Panagioti, E.; Klenerman, P.; Lee, L. N.; van der Burg, S. H.; Arens, R. Features of effective T cell-inducing vaccines against chronic viral infections. Front. Immunol. 2018, 9, 276.","journal-title":"Front. Immunol."},{"key":"4482_CR46","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s10529-020-02944-8","volume":"42","author":"Z H Qu","year":"2020","unstructured":"Qu, Z. H.; Guo, Y. L.; Li, M. Z.; Cao, C.; Wang, J. W.; Gao, M. C. Recombinant ferritin nanoparticles can induce dendritic cell maturation through TLR4\/NF-kB pathway. Biotechnol. Lett. 2020, 42, 2489\u20132500.","journal-title":"Biotechnol. Lett."},{"key":"4482_CR47","doi-asserted-by":"publisher","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","volume":"14","author":"M G Joyce","year":"2022","unstructured":"Joyce, M. G.; King, H. A. D.; Elakhal-Naouar, I.; Ahmed, A.; Peachman, K. K.; Cincotta, C. M.; Subra, C.; Chen, R. E.; Thomas, P. V.; Chen, W. H. et al. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Sci. Transl. Med. 2022, 14, eabi5735.","journal-title":"Sci. Transl. Med."}],"container-title":["Nano Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12274-022-4482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12274-022-4482-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12274-022-4482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T18:11:07Z","timestamp":1734027067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12274-022-4482-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4482"],"URL":"https:\/\/doi.org\/10.1007\/s12274-022-4482-4","relation":{},"ISSN":["1998-0124","1998-0000"],"issn-type":[{"value":"1998-0124","type":"print"},{"value":"1998-0000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}